Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,625.00    -50.00 (-1.07%)
Bid:
4,500.00
Ask:
4,750.00
Spread: 250.00 (5.556%)
Market Cap: £308.06m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Director/PDMR Shareholding

8 Jul 2016 10:20

RNS Number : 6688D
Judges Scientific PLC
08 July 2016
 

Press Release

8 July 2016

 

Judges Scientific plc

 

("Judges Scientific", "Judges", the "Company" or the "Group")

 

Director/PDMR Shareholding

 

Judges Scientific, a group involved in the buy and build of scientific instrument businesses, has today been advised that purchases of ordinary shares of 5p each in the Company ("Ordinary Shares") were made on 5 July 2016 by the Trustees of the Share Incentive Plan on behalf of two Directors of the Company, as follows:

 

A total of 20 Ordinary Shares were purchased on behalf of David Cicurel, the Chief Executive Officer of the Company. His resulting interest in the Company is 916,767 Ordinary shares representing 15.02 per cent of the issued Ordinary Share capital. In addition, he holds options over 9,275 Ordinary Shares under the Company's Share Option Plans.

 

A total of 22 Ordinary shares were purchased on behalf of Brad Ormsby, the Group Finance Director of the Company. His resulting interest in the Company is 192 Ordinary Shares representing nil per cent of the issued Ordinary Share capital. In addition, he holds options over 60,000 Ordinary Shares under the Company's Share Option Plans.

 

The purchases by the Trustees were made at a price of 1,460p per Ordinary Share. Purchases of a further 1,114 Ordinary Shares were made on the same date and at the same price on behalf of 86 other members of staff under the Company's Share Incentive Plan.

 

-Ends-

 

For further information please contact:

 

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 203 829 6970

 

Shore Capital (Nominated Adviser & Broker)

 

Stephane Auton

Edward Mansfield

Tel: +44 (0) 20 7408 4090

 

Media enquiries:

Abchurch (Financial Public Relations)

 

Julian Bosdet

Canace Wong

Nessyah Hart

Tel: +44 (0) 20 7398 7714

www.abchurch-group.com

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 14 businesses acquired since it was first admitted to AIM in 2003.

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's awards for innovation and export.

 

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

 

The Group's companies predominantly operate in niche end markets, with long term growth fundamentals and resilient margins.

 

For further information, please visit www.judges.uk.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGCGDRLBGBGLI
Date   Source Headline
15th Nov 20187:00 amRNSBlock listing Interim Review
13th Nov 20185:49 pmRNSHolding(s) in Company
6th Nov 201811:51 amRNSDirector/PDMR Shareholding
30th Oct 201810:00 amRNSTotal Voting Rights
9th Oct 20182:09 pmRNSDirector/PDMR Shareholding
18th Sep 20187:00 amRNSInterim Results
6th Sep 20184:22 pmRNSDirector/PDMR Shareholding
8th Aug 20183:25 pmRNSDirector/PDMR Shareholding
8th Aug 20187:00 amRNSIncrease in shareholding in PE Fiberoptics Limited
31st Jul 20188:21 amRNSTotal Voting Rights
27th Jul 20186:00 pmRNSDirector/PDMR Shareholding (Replacement)
27th Jul 201811:14 amRNSDirector/PDMR Shareholding
23rd Jul 20187:00 amRNSTrading Update and Notice of Interim Results
16th Jul 20187:00 amRNSHolding(s) in Company
9th Jul 20181:55 pmRNSDirector/PDMR Shareholding
15th Jun 20183:56 pmRNSHolding(s) in Company
7th Jun 20189:32 amRNSDirector/PDMR Shareholding
4th Jun 201810:48 amRNSTotal Voting Rights
30th May 20186:07 pmRNSResult of AGM
23rd May 20187:00 amRNSDirectorate Change
15th May 20187:00 amRNSBlock listing Interim Review
11th May 20187:00 amRNSDirector/PDMR Shareholding
1st May 20187:00 amRNSTotal Voting Rights
27th Apr 20189:26 amRNSNew Bank Facilities
10th Apr 20187:00 amRNSDirector/PDMR Shareholding
6th Apr 20187:00 amRNSExercise of Options and Director Dealing
20th Mar 20187:00 amRNSPreliminary Results
8th Mar 20187:00 amRNSDirector/PDMR Shareholding
1st Mar 20183:33 pmRNSTotal Voting Rights
7th Feb 201812:48 pmRNSDirector/PDMR Shareholding
1st Feb 20187:00 amRNSTotal Voting Rights
24th Jan 20185:02 pmRNSIssue of Equity - Blocklisting
15th Jan 20187:00 amRNSTrading Statement and Notice of Final Results
9th Jan 20189:32 amRNSDirector/PDMR Shareholding
9th Jan 20189:32 amRNSDirector/PDMR Shareholding
2nd Jan 201810:12 amRNSTotal Voting Rights
13th Dec 201712:27 pmRNSHolding(s) in Company
7th Dec 201710:58 amRNSDirector/PDMR Shareholding
1st Dec 20177:00 amRNSTotal Voting Rights
17th Nov 20174:43 pmRNSStandard form for notification of major holdings
16th Nov 201711:24 amRNSBlock listing Interim Review
13th Nov 20175:22 pmRNSNotification of major holdings
8th Nov 201710:15 amRNSDirector/PDMR Shareholding
1st Nov 20177:00 amRNSTotal Voting Rights
31st Oct 20177:00 amRNSAppointment of Director and Board transition
26th Oct 20172:25 pmRNSDirector/PDMR Shareholding
26th Oct 201712:19 pmRNSDirector/PDMR Shareholding
16th Oct 201712:03 pmRNSNotification of major holdings
10th Oct 20177:00 amRNSCompletion of Director Placing
9th Oct 20174:40 pmRNSPropose Director Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.